SureTrader SureTrader
Home > Boards > US OTC > Medical - Healthcare >

STARPHARMA (SPHRY)

SPHRY RSS Feed
Add SPHRY Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 11/8/2016 4:07:01 PM - Followers: 7 - Board type: Free - Posts Today: 0
Starpharma at a glance:

Starpharma is a world leader in the development of dendrimer nanotechnology-based products for pharmaceutical and life sciences. It is based in Melbourne, Australia and employs approximately 36 staff.

Dendritic Nanotechnologies Inc (DNT) is a wholly owned subsidiary based in Michigan, USA. It has approximately 16 staff.

Starpharma's lead product, VivaGel™, is a gel-based microbicide under development for the prevention of HIV infection and genital herpes.

The potential market for microbicides has been estimated at greater than a billion dollars annually.

The current incidence of HSV-2 (genital herpes) is estimated at 15-25% of the adult population in industrialised nations. This is forecast to rise substantially over the next decade. There is currently no cure for genital herpes. Prevention is the only way to deal with the risk of infection.

There are currently 40 million people living with HIV and 7,000 women are infected each day. The US Government estimates that by age 25, half of all sexually active people in the US can expect to be infected with an STI. More than 50 attempts to develop an HIV vaccine have failed. Expert opinion is that it will most likely be many years before such a vaccine becomes available, if it ever does.

VivaGel™ has shown good efficacy against HIV and HSV-2 in rigorous in vivo animal testing. VivaGel™ has completed a Phase I clinical trial and was recently granted Fast Track status by the US FDA as a product for prevention of HIV infection, accelerating the development of VivaGel™.

VivaGel™ has external development funding for both its HIV and HSV-2 indications. In 2005 the US-based NIH provided $26 million of non-diluting funding and significant support in the global development of VivaGel™ for HIV prevention. In 2006 the NIH provided additional funding support for the development of the HSV-2 indication, again without loss of product ownership by Starpharma.

VivaGel™ has a number of line extensions in development including condom coating and a gel with additional contraceptive properties.

The broader dendrimer pipeline provides Starpharma with multiple market opportunities in the fields of cancer, cardiology, ophthalmic medicine, GPCR targeting drugs and ADME engineering™.

US-based subsidiary DNT is developing nano-molecules for a range of life science and industrial applications.

DNT has a broad and comprehensive IP portfolio of approximately 180 patents/applications issued and pending.

DNT has existing revenue streams from licensing deals with leading pharmaceutical and biotechnology companies including Pfizer Inc. and Sigma Aldrich.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SPHRY
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#112   I love it when it keep going higher PEACHMAN 11/08/16 04:07:01 PM
#111   SPHRY GOING HIGHER PEACHMAN 10/27/16 04:37:09 PM
#110   http://www.thestreet.com/story/13498233/1/adama-licenses-starpharmas-priostar-de Michael Scofield 03/31/16 02:00:23 PM
#109   Nice gain today for SPHRY PEACHMAN 11/16/15 08:59:12 PM
#108   http://www.4-traders.com/STARPHARMA-HOLDINGS-LIMIT-8864716/news/Starpharma--Appe Michael Scofield 11/09/15 02:53:53 PM
#107   SPHRY has very little volume and needs awareness PEACHMAN 10/17/15 11:02:40 AM
#106   Hopefully this company will start getting some looks Michael Scofield 10/17/15 07:05:03 AM
#105   I agree that's why I took a starter position. PEACHMAN 10/16/15 04:21:15 PM
#104   This is good news. Michael Scofield 10/16/15 10:55:02 AM
#103   A friend reviewed the different phases on research PEACHMAN 10/16/15 10:47:59 AM
#102   Hello there. Nice to see a new Michael Scofield 10/16/15 09:50:54 AM
#101   Hello there. Nice to see a new Michael Scofield 10/16/15 09:50:53 AM
#100   A friend filled me in on the long PEACHMAN 10/16/15 08:17:10 AM
#99   Starpharma Holdings Announces Update on VivaGel Condom Launch Michael Scofield 12/11/14 12:35:54 PM
#98   Starpharma Holdings Announces Marketing Clearance for VivaGel Condom Michael Scofield 12/01/14 11:07:13 AM
#97   Starpharma Holdings Responds to ASX Price Query, No Michael Scofield 11/17/14 11:05:58 AM
#96   Starpharma Holdings to Launch VivaGel Condom Michael Scofield 10/02/14 04:08:01 PM
#95   Starpharma raising $23m for clinical programs Michael Scofield 09/22/14 11:56:54 AM
#94   Starpharma Holdings Trading Halted, Pending Company Announcement Michael Scofield 09/19/14 03:49:21 PM
#93   Intriguing Biotech Stocks from Australia Michael Scofield 09/10/14 11:48:34 AM
#92   Starpharma : CBCD Congratulates Starpharma (SPHRY) on the Michael Scofield 08/25/14 11:54:36 PM
#91   Global Contraceptives market will grow at 5.90% CAGR Michael Scofield 08/12/14 01:47:33 PM
#90   Starpharma To Launch Anti-Viral Condoms Michael Scofield 08/02/14 06:42:21 AM
#89   Things are heating up! Michael Scofield 07/27/14 08:59:23 PM
#88   PRESS RELEASE Michael Scofield 07/24/14 08:11:47 AM
#87   Starpharma: VivaGel Condom Receives TGA Device Certification - Michael Scofield 07/24/14 08:07:33 AM
#86   Nice couple of days! Michael Scofield 07/24/14 08:06:31 AM
#85   So glad I stumbled on to this company. Michael Scofield 07/23/14 11:10:42 AM
#84   Huge update! Michael Scofield 07/23/14 10:09:42 AM
#83   Starpharma’s dendrimer a potential viral conjunctivitis treatment flemsnopes 05/13/13 05:36:50 AM
#82   Melbourne Australia; 24 April 2013 - Starpharma Holdings flemsnopes 05/01/13 07:59:23 AM
#81   Dendrimers improve anticancer efficacy in lung metastasis model flemsnopes 03/04/13 06:49:39 AM
#80   Starpharma presenting at Bell Potter LifeScience Conference flemsnopes 11/01/12 06:02:22 AM
#79   Starpharma’s new formulations demonstrate flemsnopes 10/30/12 09:54:45 AM
#78   Nice position! flemsnopes 06/19/12 02:42:56 PM
#77   ABSOLUTELY. holding 10 k pipedream1 06/19/12 02:12:20 PM
#76   Sorry, I didn't know anyone was interested. flemsnopes 06/17/12 09:45:21 AM
#75   HELLO? pipedream1 06/14/12 07:34:09 PM
#74   Starpharma closer to VivaGel approval in Europe and US flemsnopes 11/23/11 05:17:12 AM
#73   Starpharma Holdings Limited : Cleansing Statement flemsnopes 11/21/11 07:31:23 AM
#72   Starpharma and the FDA in agreement on BV andy55q 10/10/11 10:09:43 AM
#71   Starpharma Commences Bacterial Vaginosis Prevention Study of VivaGel(R) flemsnopes 08/16/11 09:50:36 AM
#70   more good news as Starpharma is now working blackjack1955 07/12/11 05:01:46 AM
#69   Starpharma brings its novel technology to leading cancer treatment flemsnopes 06/29/11 07:29:21 AM
#68   Looking for the next entry point. flemsnopes 06/01/11 09:45:53 AM
#67   I look at this and just want to flemsnopes 06/01/11 09:44:53 AM
#66   The momentum continues. I wonder what secrets await? flemsnopes 05/25/11 07:32:38 AM
#65   VivaGel(R) Demonstrates Efficacy in Bacterial Vaginosis flemsnopes 05/25/11 07:21:19 AM
#63   this thing just keeps going.... centropomus 02/14/11 09:33:51 AM
#62   10.25 close today. So much for my market flemsnopes 02/12/11 07:33:07 AM
PostSubject